Tag Archives: Pharmia sold by CapMan to Labomar as part of strategic expansion in Nordic dietary supplements and medical devices

Labomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolio

(IN BRIEF) CapMan Buyout has sold Pharmia Holding Oy, the leading Nordic contract manufacturer of dietary supplements and medical devices, to Labomar, an Italy-based European group owned by Charterhouse Capital Partners. Since CapMan’s investment in 2021, Pharmia has grown into … Read the full press release